| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |